Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|10|2|90-96

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.10, Iss.2, 2014-05, pp. : 90-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Clonal Hierachy in Multiple Myeloma

By Rasmussen Thomas   Jensen Linda   Johnsen Hans Erik  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 765-770

Informa Healthcare

Access to resources Recommend Favorite

Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma

By  

Current Cancer Therapy Reviews, Vol. 10, Iss. 2, 2014-05 ,pp. : 70-79

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin

By Chang H.   Wechalekar A.   Li L.   Reece D.  

Cancer Genetics and Cytogenetics, Vol. 148, Iss. 1, 2004-01 ,pp. : 44-48

Elsevier

Access to resources Recommend Favorite

Evidence that aberrant protein metabolism contributes to chemoresistance in multiple myeloma cells

By Sipes Richard K.   Xia Xue   Lewis Brian S.   Burgis Nicholas E.  

Oncology Reports, Vol. 27, Iss. 6, 2012-06 ,pp. : 2031-2038

Spandidos Publications

Access to resources Recommend Favorite

Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma: Proof of Common Clonal Origin

By Sucker Christoph   Krämer Alwin   Moos Marion   Goldschmidt Hartmut  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 2, 2004-06 ,pp. : 81-84

Springer Publishing Company

Access to resources Recommend Favorite